Response Evaluation Using 68Ga-DOTA-IBA in a Case of Metastatic Prostate Cancer

Abstract We report a case of a patient with metastatic prostate cancer receiving first-line endocrine therapy. Clinical symptoms, PSA level, and CT confirmed the significant progression of his bone metastatic lesions. In comparison to images at baseline, follow-up bone scan incorrectly showed remission of the bone lesions, whereas follow-up 68 Ga-DOTA-IBA correctly showed disease progression.